BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29358879)

  • 1. Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data.
    Xue WH; Fan ZR; Li LF; Lu JL; Ma BJ; Kan QC; Zhao J
    World J Gastroenterol; 2018 Jan; 24(1):23-34. PubMed ID: 29358879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computationally constructed ceRNA interaction network based on a comparison of the SHEE and SHEEC cell lines.
    Sun J; Yan J; Yuan X; Yang R; Dan T; Wang X; Kong G; Gao S
    Cell Mol Biol Lett; 2016; 21():21. PubMed ID: 28536623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lnCeDB: database of human long noncoding RNA acting as competing endogenous RNA.
    Das S; Ghosal S; Sen R; Chakrabarti J
    PLoS One; 2014; 9(6):e98965. PubMed ID: 24926662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-378a-5p exerts tumor-suppressive effects on esophageal squamous cell carcinoma after neoadjuvant immunotherapy by downregulating APOC1/CEP55.
    Pengjie Y; Rong J; Pengfei N
    Sci Rep; 2024 Jan; 14(1):305. PubMed ID: 38172247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma.
    Ding X; Qi C; Min J; Xu Z; Huang K; Tang H
    J Cell Mol Med; 2020 Sep; 24(18):10551-10559. PubMed ID: 32729661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
    Tian S; Wang C; Zhang J; Yu D
    BMC Med Genomics; 2020 Feb; 13(1):18. PubMed ID: 32024523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CeModule: an integrative framework for discovering regulatory patterns from genomic data in cancer.
    Xiao Q; Luo J; Liang C; Cai J; Li G; Cao B
    BMC Bioinformatics; 2019 Feb; 20(1):67. PubMed ID: 30732558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering lncRNA mediated sponge interactions in breast cancer molecular subtypes.
    Olgun G; Sahin O; Tastan O
    BMC Genomics; 2018 Sep; 19(1):650. PubMed ID: 30180792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crinet: A computational tool to infer genome-wide competing endogenous RNA (ceRNA) interactions.
    Kesimoglu ZN; Bozdag S
    PLoS One; 2021; 16(5):e0251399. PubMed ID: 33983999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic exploration of autonomous modules in noisy microRNA-target networks for testing the generality of the ceRNA hypothesis.
    Yip DK; Pang IK; Yip KY
    BMC Genomics; 2014 Dec; 15(1):1178. PubMed ID: 25539629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ceRNA networks in gynecological cancers progression and resistance.
    Wu S; Zhong B; Yang Y; Wang Y; Pan Z
    J Drug Target; 2023 Dec; 31(9):920-930. PubMed ID: 37724808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data.
    Wang P; Guo Q; Gao Y; Zhi H; Zhang Y; Liu Y; Zhang J; Yue M; Guo M; Ning S; Zhang G; Li X
    Oncotarget; 2017 Jan; 8(3):4642-4655. PubMed ID: 27992375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of endometrial competing endogenous RNA network in infertile women of childbearing age.
    Zhang M; Li J; Duan S; Fang Z; Tian J; Yin H; Zhai Q; Wang X; Zhang L
    Aging (Albany NY); 2020 Feb; 12(5):4204-4221. PubMed ID: 32112646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRTissue
    Fiannaca A; Paglia L; Rosa M; Rizzo R; Urso A
    BMC Bioinformatics; 2020 Sep; 21(Suppl 8):199. PubMed ID: 32938402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress in lncRNA and its action as ceRNA in ovarian function as well as the relevant diseases.
    Li Y; Chen J; Luo Q; Tan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):745-752. PubMed ID: 34382592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.
    Lai X; Eberhardt M; Schmitz U; Vera J
    Nucleic Acids Res; 2019 Sep; 47(15):7753-7766. PubMed ID: 31340025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotiana benthamiana as a model plant host for Fusarium verticillioides to investigate RNA interference, cross-kingdom RNA exchange, and competitive endogenous RNA (ceRNA) network.
    Aydinoglu F; Kuloglu A
    Mol Biol Rep; 2023 Oct; 50(10):8061-8072. PubMed ID: 37540455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing endogenous RNA crosstalk at system level.
    Miotto M; Marinari E; De Martino A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007474. PubMed ID: 31675359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story.
    Ala U
    Cells; 2020 Jun; 9(7):. PubMed ID: 32605220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing endogenous RNAs in head and neck squamous cell carcinoma: a review.
    Agrawal A; Vindal V
    Brief Funct Genomics; 2023 Nov; ():. PubMed ID: 37941447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.